Secukinumab pens for Belfast's health trust come from Novartis
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 29 September 2026 to 30 September 2028
Belfast Health and Social Care Trust is buying secukinumab from Novartis Pharmaceuticals UK Limited. The medicine comes as a 300 mg pre-filled injection pen, sold in single-pen packs.
The trust awarded the supply contract directly to Novartis in September 2026, without a competition. The contract is worth £280,000 and runs to September 2028.
Contract ends September 2028
- What
- Medicines supply
- Value
- £280,000
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Sep 2028